Gilead Sciences said Wednesday preliminary results of a coronavirus drug trial showed at least 50% of patients treated with a five-day dosage of remdesivir improved and more than half were discharged from the hospital within two weeks. The company also said another trial by the National Institute of Allergy and Infectious Diseases met its main goal.…
On 11 March, the World Health Organization classified the COVID-19 outbreak as a pandemic. The disease has reached nearly every country, infecting hundreds of thousands of people and killing thousands. Currently, there are no FDA-approved therapies or vaccines for SARS-CoV-2, the virus that causes COVID-19. The National Institute of Allergy and Infectious Diseases (NIAID) within…
Early peek at data on Gilead coronavirus drug suggests patients are responding to treatment
The Paycheck Protection Program has exhausted its $350 billion allocation and is not accepting any more lenders or applications at this time, the Small Business Administration announced Thursday. However, “there are active efforts on the Hill to extend it and that could happen as soon as Friday,” said Scott Sinder of the law firm Steptoe…
The Treasury Department and Internal Revenue Service reversed their stance late Wednesday that Social Security beneficiaries would need to file tax returns in order to receive direct cash assistance payments under the Coronavirus Aid, Relief and Economic Security (CARES) Act. Treasury will now provide automatic coronavirus relief payments for Social Security beneficiaries. “Social Security recipients…
The U.S. is short of ventilators. It’s something American manufactures aim to change—rapidly. It is a modern day “Arsenal of Democracy.” Ford Motor (ticker: F) and General Electric (GE) are partnering to build ventilators in a new venture announced Monday. Production “will start the week of April 20,” a Ford representative said on a Monday afternoon media call. Ford…